Auxo Medical Franchising

The vendor opportunity at Auxo Medical

Auxo Medical Franchising is a health-services concept headquartered in Virginia with a total footprint of 4 units, split between 1 franchised location and 3 company-owned outlets. For software vendors, this represents a very small immediate addressable market. The franchisor charges an 8.0% royalty and signs franchisees to a 10-year initial term. No average unit volume (AUV) is disclosed in the 2023 FDD, and year-over-year unit growth is not available in our corpus. Vendors evaluating this brand should weigh the limited current scale against the potential to land as an early technology partner before any expansion.

Who controls software purchasing

Technology decisions at Auxo Medical are centralized at the headquarters level. The 2023 FDD lists three executives in Item 1: Jay Crabtree, Chief Executive Officer; Anthony Frank, Chief Operating Officer; and Tanner Seese, Chief Marketing Officer. In a system this small, all three individuals are likely involved in software evaluation and procurement. The CEO holds ultimate budgetary authority, while the CMO may champion customer-facing or CRM tools. No dedicated CIO, CTO, or VP of Technology is named in the disclosure, which is typical for a 4-unit franchisor. Vendors should prepare to engage directly with the C-suite rather than a specialized IT procurement function.

Mandated and current tech stack

The only technology mandate appearing in the 2023 FDD is for customer relationship management (CRM) software. The specific vendor or platform is not named in the disclosure, leaving an open question for vendors who want to understand the incumbent. No point-of-sale, scheduling, inventory, or accounting systems are listed as mandated or recommended. This narrow tech stack suggests Auxo Medical is either in the early stages of building its technology infrastructure or operates with minimal franchisee-facing software requirements. Vendors selling complementary tools—such as marketing automation, patient engagement, or compliance platforms—may find a greenfield opportunity, provided they can demonstrate value to a small, HQ-controlled network.

Procurement, renewals, and timing

The 2023 FDD does not contain an Item 8 procurement extract, so the franchisor's formal purchasing model remains unclear. It is unknown whether Auxo Medical designates specific suppliers, maintains an approved vendor list, or permits franchisees to purchase technology independently. On the renewal side, Item 17 outlines a 5-year renewal term available to franchisees who are in compliance, provide 180 days' prior written notice, and sign the then-current franchise agreement. The renewal agreement may contain materially different terms, including updated technology requirements. With only one franchised unit, the near-term pipeline for renewal-driven software evaluations is effectively nonexistent. Vendors should monitor for new unit openings or changes to the franchisor's tech mandates as signals of a potential sales window.

How to read the Auxo Medical FDD

The 2023 Franchise Disclosure Document is the authoritative source for understanding Auxo Medical's technology requirements, procurement rules, and financial performance. Key sections for software vendors include Item 11 (Franchisor's Obligations), which details mandated and recommended systems, and Item 17 (Renewal), which governs when franchisees must revisit their contracts and potentially their tech stacks. The embedded PDF viewer below provides full access to the document. For a ranked target list of franchise brands matched to your software category, FranCloud can help you prioritize your outreach.